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Although inhalation of infected aerosols is a frequent route for Brucella infection in 
humans, it rarely causes pulmonary clinical manifestations, suggesting a mild or nearly 
absent local inflammatory response. The goal of this study was to characterize the 
early innate immune response to intratracheal infection with Brucella abortus in mice 
and to evaluate whether it is modulated by this pathogen. After infection with 106 CFU 
of B. abortus, the pulmonary bacterial burden at 7  days post-infection (p.i.) was 
comparable to the initial inoculum, despite an initial transient decline. Brucella was 
detected in spleen and liver as early as 1 day p.i. IL-1β and MCP-1 increased at 3 days 
p.i., whereas IL-12, KC, TNF-α, and IFN-γ only increased at 7 days p.i. Histological 
examination did not reveal peribronchial or perivascular infiltrates in infected mice. 
Experiments were conducted to evaluate if the limited inflammatory lung response to 
B. abortusis caused by a bacterial mechanism of TLR signaling inhibition. Whereas 
inoculation of E. coli LPS to control mice [phosphate-buffered saline (PBS)/LPS] 
caused lung inflammation, almost no histological changes were observed in mice 
preinfected intratracheally with B. abortus (WT/LPS). We speculated that the Brucella 
TIR-containing proteins (Btps) A and B, which impair TLR signaling in vitro, may be 
involved in this modulation. After LPS challenge, mice preinfected with the B. abortus 
btpAbtpB double mutant exhibited a stronger pulmonary polymorphonuclear infiltrate 
than WT/LPS mice, although milder than that of the PBS/LPS group. In addition, lungs 
from B. abortus btpAbtpB-infected mice presented a stronger inflammatory infiltrate 
than those infected with the WT strain, and at day 7 p.i., the pulmonary levels of KC, 
MCP-1, and IL-12 were higher in mice infected with the mutant. This study shows 
that B. abortus infection produces a mild proinflammatory response in murine lungs, 
partially due to immune modulation by its Btp proteins. This may facilitate its survival 
and dissemination to peripheral organs.
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inTrODUcTiOn
Brucellosis is a worldwide-distributed zoonotic disease caused 
by Brucella species that affects over 500,000 people annually (1). 
Most cases are caused by Brucella melitensis, Brucella suis, and 
Brucella abortus. The infection can be transmitted to humans by 
several ways, among which inhalation of infected aerosols is one 
of the most frequent. Several reports place airborne transmission 
as the cause of outbreaks of human brucellosis in bovine and 
porcine slaughterhouses, vaccine production laboratories, and 
rural areas (2–5). Notably, aerosols have been implicated in most 
cases of laboratory-acquired brucellosis, which is considered 
the most common laboratory-acquired infection (6). Due to its 
easy aerosolization, high infectivity and air borne transmission, 
Brucella species are considered potential biological weapons (1) 
and are classified by the CDC and NIAID as category B bioter-
rorism agents.
Airborne Brucella infection rarely causes pulmonary clinical 
manifestations in infected humans. In case series in which inhala-
tion of organisms was strongly suspected as the most probable 
source of infection, lung pathology was extremely rare (4, 7, 8). 
These observations suggest that, in spite of the high infectivity of 
Brucella through inhalation, an inflammatory immune response 
against the pathogen is mild or nearly absent in the lungs. Brucella 
species use diverse mechanisms to evade innate immunity, some 
of which may contribute to a limited inflammatory response to 
the pathogen in the lungs. The ability of Brucella to impair TLR 
signaling may be particularly important in this regard (9, 10).
The innate immune response against Brucella is of great 
importance because it determines the course of the adaptive 
response (11, 12), which is key for the control of Brucella infec-
tion. A critical step for the initiation of the innate immune 
response is the detection of microbial PAMPs by TLR receptors. 
TLR9 has been shown to be required to eliminate B. abortus 
in infected mice (13). Similarly, mice deficient in MyD88 (the 
adaptor molecule for all TLRs except TLR3) are highly suscep-
tible to Brucella infection (11, 13, 14). Although TLR2 does 
not seem to be essential for Brucella control in infected mice 
(11, 15), it has been extensively shown that signaling through 
TLR2 contributes to the production of proinflammatory 
cytokines by Brucella-infected phagocytic and non-phagocytic 
cells (16–19). The role of TLR4 remains controversial. Whereas 
some studies show that TLR4 is required to control Brucella 
infection (15), others do not reveal such requirement in spite 
of the importance of this receptor for TNF-α production (11). 
Although the role of TLR5 in Brucella infections has not been 
explored in vivo, it has been shown that Brucella flagellin is not 
recognized by human TLR5 (20).
Notably, Brucella expresses two proteins that impair signal-
ing through TLR2, TLR4, TLR5, and TLR9, named Brucella 
TIR-containing proteins (Btps) A and B (9, 10). Although these 
proteins have been shown to reduce cytokine secretion by cells 
infected with Brucella in vitro, a potential role of Btps in the ability 
of Brucella to survive in immunocompetent hosts has not been 
investigated.
A previous study reported that B. abortus can infect Balb/c 
mice through aerosols and can persist at high numbers in the 
lungs for several weeks, suggesting that an effective pulmonary 
immune response is not mounted in these hosts (21). In that 
study, Brucella CFU counts were determined on a weekly basis, 
but CFU kinetics and immune response within the first days of 
infection were not addressed. The aim of the present study was 
to characterize the innate immune response in the lungs of mice, 
and the bacterial dissemination to peripheral organs, during the 
first days after intratracheal infection with B. abortus. A potential 
role of Btps in the modulation of the lung immune response to 
the infection and to the stimulation with TLR agonists was also 
investigated.
MaTerials anD MeThODs
animals
Male 7- to 8-week-old Balb/c mice were used in all experiments. 
The animals were housed in BSL3 facilities (IIB-INTECH-
UNSAM, Buenos Aires, Argentina). Animals were housed in 
groups of five animals, under controlled temperature (22 ± 2°C) 
and artificial light under a 12-h cycle period. All experimental 
protocols of this study were conducted in agreement with inter-
national ethical standards for animal experimentation (Helsinki 
Declaration and its amendments, Amsterdam Protocol of welfare 
and animal protection, and National Institutes of Health, USA, 
guidelines: Guide for the Care and Use of Laboratory Animals). 
The protocols of this study were approved by the Institutional 
Committee for the Care and Use of Experimentation Animals 
from the University of San Martin (UNSAM).
Bacterial strains and growth conditions
Brucella abortus 2308 (wild-type strain, WT) and its isogenic 
B. abortus btpAbtpB double mutant (9) were grown in tryptic 
soy broth at 37°C with agitation until reaching an approxi-
mate OD600 of 1.0. Bacteria were washed twice with sterile 
phosphate-buffered saline (PBS), and inocula were prepared in 
sterile PBS on the basis of the optical density readings, but the 
actual concentration was later checked by plating on tryptic soy 
agar (TSA). All live Brucella manipulations were performed in 
biosafety level 3 facilities.
intratracheal inoculation
Animals were inoculated intratracheally with B. abortus WT or 
B. abortus btpAbtpB mutant as previously described (22) with 
minor modifications. Briefly, animals were anesthetized with 
isoflurane, and after becoming recumbent, were injected intra-
peritoneally with a mixture of ketamine and xylazine (100 and 
8  mg/kg). Mice were placed in supine position over an acrylic 
backboard and restrained by the teeth using a rubber band. 
Under translucent illumination of the trachea, the inoculum was 
injected in a final volume of 20 µl in between the vocal cords with 
a Hamilton syringe coupled to a blunt-ended probe, to deliver 
106 CFU per mice. Control mice received 20 µl of PBS following 
the same procedure.
cFU and cytokine analysis
At different time points post-infection (p.i.), mice were eutha-
nized by an intraperitoneal injection of a lethal dose of ketamine 
FigUre 1 |  Brucella abortus persists in lungs but disseminates to peripheral 
organs in the first week after intratracheal infection. Mice were infected with 
106 CFU/mouse of B. abortus WT, and CFU numbers were determined in 
lung, liver, and spleen homogenates at different times post-infection (p.i.) 
(n = 5–8 per time point).
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and xylazine, and their lungs, liver, and spleens were harvested. 
The whole organs were homogenized in 2  ml sterile PBS, and 
serial dilutions of homogenate aliquots were plated on TSA 
for CFU counting. The remaining homogenate volumes were 
centrifuged for 15 min, and the supernatants were mixed with 
protease inhibitors (cOmplete™, Roche) and stored at −70°C for 
cytokine and chemokine determination by commercial ELISA 
kits (R&D), according to the manufacturer’s instructions.
Bronchoalveolar lavage Fluid (BalF)
Mice were euthanized, their tracheas were cannulated, and the 
airways were perfused several times with 0.7 ml of sterile cold 
PBS containing 1  mM EDTA to provide 4  ml of BALF. BALF 
samples were centrifuged at 400  ×  g for 10  min at 4°C and 
supernatants were stored at −70°C for cytokine measurements 
as described above.
histological examination
At 2 and 7  days p.i., lungs were harvested and fixed in 4% 
paraformaldehyde for 24 h, then embedded in paraffin and cut in 
5-µm sections. The samples were stained with hematoxylin and 
eosin and blindly analyzed by a pathologist. Tissue damage was 
graded using a previously described scoring system (23), as fol-
lows: 0 (normal = no inflammation), 1 (minimal = perivascular, 
peribronchial, or patchy interstitial inflammation involving less 
than 10% of lung volume), 2 (mild =  perivascular, peribron-
chial, or patchy interstitial inflammation involving 10–20% 
of lung volume), 3 (moderate  =  perivascular, peribronchial, 
patchy interstitial, or diffuse inflammation involving 20–50% of 
lung volume), and 4 (severe =  diffuse inflammation involving 
more than 50% of lung volume).
inhibition of lPs-induced airway 
inflammation
Mice were intratracheally inoculated with PBS or with 
106 CFU/mouse of either B. abortus WT or B. abortus btpAbtpB 
mutant as described above, and 24 h later were intratracheally 
inoculated with 5  µg of E. coli LPS (Sigma-Aldrich). Lungs 
were harvested 24  h later, fixed in paraformaldehyde 4%, 
and subjected to histological analysis as described above.
Pulmonary innate immune response 
stimulation
Mice were intratracheally inoculated with 5  µg of E. coli LPS 
and 24 h later were intratracheally inoculated with PBS or with 
106 CFU of either B. abortus WT or B. abortus btpAbtpB mutant. 
Lungs were harvested 24 h later, homogenized, and analyzed for 
cytokines and CFU counts.
statistical analysis
Statistical comparisons for significant differences were perfor-
med with the ANOVA test followed by Tukey’s test or Dunnett’s 
test using GraphPad 5.0 software. Normality was assessed by 
the D’Agostino–Pearson test. Data are means ± SEM from at least 
three independent experiments. A p value <0.05 was considered 
as statistically significant.
resUlTs
Kinetics of Brucella infection in lungs  
and Dissemination to Peripheral Organs
Mice were intratracheally infected with B. abortus WT, and 
CFU numbers were determined in lung, liver, and spleen 
homogenates at different times within the first week p.i. As 
shown in Figure 1, the pulmonary bacterial burden diminished 
non-significantly during the first days p.i. but then rapidly 
reached values similar to the initial inoculum. Brucella could 
disseminate from the initial infection site and was recovered 
as early as 1 day p.i. from spleen and liver. The bacterial load 
in liver and spleen tended to increase at 7 days (168 h) p.i. as 
compared to previous days, although the difference did not 
reach statistical significance probably due to data dispersion 
(Dunnett’s test versus 24 h p.i.).
B. abortus induces a Mild inflammatory 
response in Murine lungs
To assess the early pulmonary cytokine response induced by 
the intratracheal infection with B. abortus WT, levels of IL-1β, 
TNF-α, IFN-γ, IL-12, MCP-1, and KC were measured in lung 
homogenates from infected mice. A significant increase in 
IL-1β and MCP-1 concentration was found at 3  days p.i. as 
compared to non-infected mice, whereas a significant increase 
in IL-12, KC, TNF-α, and IFN-γ was detected only at 7 days p.i. 
(Figure  2A). Due to sample volume limitations, only TNF-α  
and IL-1β could be determined in BALF. Both cytokines 
tended to be higher in BALF from infected mice than in con-
trol mice, but differences did not reach significant differences 
(Figure 2B). Overall, these results suggest a delayed cytokine 
response to B. abortus in the lungs of mice infected through the 
intratracheal route.
FigUre 2 | Brucella abortus induces a delayed and mild inflammatory response. Mice (n = 5) were infected intratracheally with 106 CFU of B. abortus (gray bars) 
and cytokines were measured at different times post-infection (p.i.) in lung homogenates (a) and bronchoalveolar lavage fluid (BALF) (B). Controls inoculated with 
phosphate-buffered saline through the same route (white bars) were assessed in parallel. Differences between groups were analyzed by ANOVA followed by Tukey’s 
test (*p < 0.05, **p < 0.01). Histological changes in lungs were assessed in infected and control mice at 2 and 7 days post-inoculation (c). Magnification, ×20. 
Bar = 50 µm.
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Cellular infiltrates are commonly found in lungs as compo-
nents of the innate immune response to infection by inhaled 
pathogens. Therefore, we assessed histological changes in lungs 
of mice infected with B. abortus WT, as compared to non-infected 
controls. As shown in Figure 2C, at 2 days p.i., no peribronchial 
or perivascular infiltrates were present in infected mice, and 
only a mild and focalized lymphocytic interstitial infiltrate and a 
few points of hematic extravasation were noticed. The interstitial 
infiltrate was milder at day 7 p.i., and some hematic extravasa-
tion foci were also observed.
Brucella actively suppresses Tlr4-
Mediated lung inflammation
The limited inflammatory response elicited by B. abortus in the 
lungs of infected mice may be due to some of the immune eva-
sion mechanisms of Brucella, such as the secretion of proteins 
that interfere with TLR signaling thus downmodulating cytokine 
production (24, 25). Therefore, experiments were conducted 
to evaluate if B. abortus was capable to actively suppress lung 
inflammation caused by E. coli LPS, a potent TLR4 agonist. Mice 
were infected intratracheally with B. abortus, or administered 
with PBS as a control, and 24 h later received E. coli LPS by the 
intratracheal route. The following day mice were euthanized, 
and their lungs were harvested for cytokine measurement and 
histological examination.
As shown in Figure 3A (left panel), LPS inoculation to mice 
previously administered with PBS (PBS/LPS group) causes lung 
inflammation, as expected for a TLR4 agonist. Lungs exhib-
ited vascular congestion, edema, and focal points of hematic 
extravasation in the alveoli, along with an important infiltrate 
of polymorphonuclear cells. This inflammatory reaction was 
markedly abolished in mice preinfected with B. abortus WT 
(WT/LPS) as only mild vascular congestion and edema were 
observed (Figure 3A, middle panel). As shown in Figure 3B, the 
inflammatory score found in lungs from the WT/LPS group was 
significantly lower than that found in the PBS/LPS group. These 
results show that B. abortus modulates the pulmonary innate 
immune response to a TLR4 agonist.
As part of the wide repertoire of Brucella immune evading 
effectors, two proteins have been described, namely, Brucella 
TIR-containing proteins A (BtpA) and B (BtpB), which inter-
fere with TLR signaling and innate immune responses (9, 10). 
To test whether these proteins are involved in the modulation of 
LPS-mediated inflammation, mice were intratracheally infected 
with a B. abortus double mutant for the Btp proteins (B. abortus 
btpAbtpB), and 24 h later were inoculated with E. coli LPS through 
the same route.
As compared to the lungs of mice preinfected with the WT 
strain (WT/LPS), those of mice infected with the double mutant 
(btpAbtpB/LPS) exhibited an important polymorphonuclear 
infiltrate and some hematic extravasation focal points (Figure 3A, 
right panel). Nevertheless, the polymorphonuclear infiltrate of 
the btpAbtpB/LPS group was still milder than that of the PBS/
LPS group. Lungs from both WT/LPS and btpAbtpB/LPS groups 
had less vasocongestion than those from the PBS/LPS group. 
FigUre 3 | Brucella preinfection suppresses TLR4-mediated lung inflammation. Mice (n = 5) were infected intratracheally with 106 CFU of Brucella abortus 2308 
(WT) or a double mutant for BtpA and BtpB proteins (btpAbptB), or were inoculated with phosphate-buffered saline (PBS) as a control, and 24 h later received  
E. coli LPS by the intratracheal route. The next day mice were euthanized and their lungs were harvested for histological examination (a,B) and for preparing 
homogenates for cytokine measurement (c). (B) **p < 0.001, ***p < 0.001, Tukey’s multiple comparison test; (c) *p < 0.05, ***p < 0.001 vs. the PBS/LPS  
group. Magnification, ×20. Bar = 50 µm.
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As shown in Figure 3B, the inflammatory score found in lungs 
from the btpAbtpB/LPS group was significantly higher than that 
found in the WT/LPS group, but lower than that in the PBS/LPS 
group. Altogether, these results indicate that the immunosup-
pression observed in mice from WT/LPS group is partly due to 
the Btp proteins of Brucella.
The modulatory effect of Btp proteins in this model was also 
evidenced at the cytokine level (Figure 3C). The levels of IFN-γ 
in lung homogenates were significantly lower in mice from the 
WT/LPS group than in those from the btpAbtpB/LPS group, 
and a similar tendency was observed for IL-1β, KC, and MCP-1 
levels. In agreement with the reduced inflammatory infiltrate in 
the WT/LPS group versus the PBS/LPS group, levels of the KC 
and MCP-1 chemokines tended to be lower in the first group.
Btp Proteins Modulate the lung 
inflammatory response to B. abortus
The role of Btp proteins in the course of a Brucella infec-
tion acquired through a natural route is still unknown. We 
6Hielpos et al. Lung Innate Response to B. abortus
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hypo thesized that Btp proteins could contribute to modulate 
the innate response in lungs during a respiratory infec-
tion with Brucella. To test this hypothesis, we evaluated the 
pulmonary histology and cytokine response of mice infected 
intratracheally with either B. abortus WT or the B. abortus 
btpAbtpB mutant. The cytokine analysis revealed no significant 
differences in proinflammatory cytokines (IL-1β, IFN-γ, IL-12, 
and TNF-α) and chemokines (KC and MCP-1) at 2  days p.i. 
However, at day 7 p.i., there was a significant increase of IL-12, 
KC, and MCP-1 in btpAbtpB-infected lungs when compared 
with WT-infected lungs (Figure  4A), and a similar but non-
significant tendency was observed for IL-1β and IFN-γ. Lungs 
from btpAbtpB− infected mice presented a higher level of 
inflammatory infiltrate than those from WT-infected mice at 
both 2  days p.i. (Figures  4B,C) and 7  days p.i. (not shown). 
Despite this stronger proinflammatory profile in lungs of mice 
infected with the Btp mutant, no significant differences in CFU 
counts were observed in comparison with WT infection at 2 or 
7 days p.i. (Figure 4D).
Btp Proteins Protect B. abortus from 
Tlr4-induced lung inflammation
As shown above, despite the increased levels of cytokines and 
the increased inflammatory infiltrate in the lungs of btpAbtpB-
infected mice as compared to WT-infected controls, CFU 
counts of the mutant did not change during the first week 
of infection. This suggests that the defensive mechanisms 
mounted during the first stages of infection are not enough to 
reduce the pulmonary load of Brucella, even if the bacterium is 
devoid of Btp proteins. To test whether a stronger pulmonary 
innate immune response could reduce the number of Brucella 
CFU in lungs, mice were administered with an intratracheal 
dose of E. coli LPS (5 μg/mouse) and 1 day post-administration 
were inoculated through the same route with PBS, B. abortus 
WT, or B. abortus btpAbtpB. The day after infection, lungs of 
the different groups were collected and analyzed for cytokines 
and CFU. At 24 h p.i. (48 h after LPS treatment), the pulmonary 
levels of several proinflammatory cytokines (IL-1β, IL-12, 
MCP-1, and KC) were significantly higher in the LPS/btpAbtpB 
group than in the LPS/WT group, suggesting that Btp proteins 
modulate the proinflammatory response elicited by the LPS 
pretreatment (Figure  5B). At this time point, the cytokine 
response to WT infection did not differ significantly between 
PBS- and LPS-pretreated mice, except for IFN-γ which was 
significantly increased in LPS-pretreated animals. By contrast, 
among animals infected with the btpAbtpB mutant, the levels 
of all cytokines, except for TNF-α, were significantly higher 
in LPS-conditioned lungs than in those pretreated with PBS. 
As shown in Figure  5A, there was no significant difference 
in CFU counts between lungs from WT-infected mice previ-
ously treated with either LPS or PBS. Among mice infected 
with the btpAbtpB mutant, by contrast, CFU numbers were 
significantly reduced in LPS-conditioned lungs as compared 
to those pretreated with PBS. Globally, these results suggest 
that Btp proteins play a role in Brucella survival within a strong 
inflammatory environment.
DiscUssiOn
The airborne route of infection has been widely shown to be 
epidemiologically important in human and animal brucellosis. 
After entry through inhalation, bacteria of the Brucella genus can 
disseminate from the lungs to the rest of the organism. However, 
pulmonary manifestations have been only exceptionally reported 
in patients who acquired Brucella infection through inhalation 
of contaminated aerosols (4). This should not be confused with 
cases of pulmonary brucellosis (including pneumonia and 
pleural effusion), which have been described in some series on 
human brucellosis. In these series, consumption of unpasteur-
ized dairy products was the most common source of infection, 
strongly suggesting that Brucella had reached the lungs through 
hematogenous dissemination (26–28). The scarcity of pulmonary 
manifestations in patients with airborne-acquired brucellosis 
suggests that, in spite of the high infectivity of Brucella through 
inhalation, an inflammatory immune response against the patho-
gen is mild or nearly absent in the lungs.
In this study, we demonstrated that B. abortus intratracheal 
infection produces a mild proinflammatory response in lungs 
of infected Balb/C mice partly due to immune modulation. 
The cytokine response and the histological analysis in lungs 
showed minimal alterations in infected animals, and such 
changes started as late as 3 days p.i. This lack of vigorous inflam-
matory response may partially explain the steady CFU counts of 
B. abortus in murine lungs during the 1-week follow-up of the 
present study. Notably, a longer bacteriological follow-up after 
infection with aerosolized B. abortus found steady pulmonary 
CFU counts for up to 8 weeks p.i (21). In line with our findings, 
a recent study on intranasal infection with B. melitensis in mice 
also reported invariable levels of CFU during the first 12 days p.i 
(29). Although the later study used a different Brucella species 
and a different delivery method as compared to our study, it also 
revealed a lack of significant inflammatory response in the lungs 
of infected mice. However, the mechanisms underlying this lack 
of inflammation were not explored.
The limited inflammatory response elicited by B. abortus in 
the lungs of infected mice may be due to some of the immune 
evasion mechanisms of Brucella, which include poor immu-
nostimulating antigens and active suppression mechanisms 
(9, 24, 29). Among the latter, the action of Btp proteins, which 
contain TIR motifs that interact with TIR-containing compo-
nents of the TLR signaling cascade, is especially remarkable 
(24, 25). Btp proteins have been shown to downmodulate the 
secretion of proinflammatory cytokines by Brucella-infected 
dendritic cells, and to reduce the formation of splenic granulomas 
in infected mice. Therefore, the interference with TLR signaling 
through the action of Btp proteins was considered a plausible 
mechanism for the mild inflammatory response to B. abortus in 
our model. Experiments were conducted to evaluate if B. abortus 
was capable of actively suppressing lung inflammation caused 
by E. coli LPS, a potent TLR4 agonist. B. abortus preinfection 
not only inhibited the LPS-induced recruitment of phagocytes 
to the lungs but also reduced the pulmonary production of some 
proinflammatory cytokines in response to LPS. Notably, when 
mice were preinfected with the B. abortus btpAbtpB double 
FigUre 4 | Btp proteins modulate the lung inflammatory response to Brucella abortus. Mice (n = 5) were infected intratracheally with 106 CFU of either B. abortus 
WT or B. abortus btpAbtpB mutant, or received phosphate-buffered saline (PBS) through the same route as a control. At 2 and 7 days post-infection (p.i.), animals 
were sacrificed and their lungs were obtained to evaluate cytokine response (a), histology (B,c), and colony-forming units (D). *p < 0.05, **p < 0.01, ***p < 0.001 
versus NI. Magnification, ×20. Bar = 50 µm.
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FigUre 5 | Btp proteins protect Brucella abortus from TLR4-induced lung inflammation. Mice (n = 5) were administered with an intratracheal dose of E. coli  
LPS (5 μg/mouse) and one day post-administration were inoculated with phosphate-buffered saline (PBS), B. abortus WT or B. abortus btpAbtpB mutant.  
The day after infection, lungs of the different groups were collected and analyzed for CFU (a) and cytokines (B) (*p < 0.05, **p < 0.01, ***p < 0.001).
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mutant, this inhibitory effect on LPS-induced inflammation 
was partially lost, as revealed by histology analysis and KC 
measurement. This suggests that Btps are partially responsible 
for the inhibitory effect, although additional immune evasion 
mechanisms may be also involved in the ability of B. abortus to 
inhibit LPS-induced pulmonary inflammation. The btpAbtpB/
LPS group presented less inflammatory infiltrate than the PBS/
LPS group in spite of higher levels of IL-1β and IFN-γ. The 
reduced inflammatory infiltrate may not be due to differences in 
the chemokines measured (MCP-1 and KC), which were similar 
in both groups, suggesting that other cytokines not measured in 
the present study may be involved.
Btp proteins also seemed to exert immunomodulation in the 
context of pulmonary B. abortus infection, as a greater degree of 
lung inflammation was detected in mice intratracheally infected 
with the btpAbtpB mutant than in those infected with the WT 
strain. However, this increased inflammation did not translate 
into an enhanced infection control, as there were no differences 
at 2 or 7 days p.i. in the pulmonary CFU counts of the mutant as 
compared to the WT strain. These findings suggest that, regard-
less of the expression of Btp proteins, the immune response 
mounted in the lung during the first stages of infection is not 
enough to reduce the pulmonary load of Brucella. In line with 
these findings, a recent study has also suggested that the pulmo-
nary inflammatory response is irrelevant for the early control of 
B. melitensis after intranasal infection, as pulmonary CFU counts 
did not differ between wild-type mice and those deficient for 
IL-1R, IL-6, TNF-α, or CCR2 (29).
Experiments were carried out in the present study to test 
whether a stronger innate immune response in the lungs could 
reduce the pulmonary CFU counts of Brucella, and whether Btps 
may have a role in Brucella survival in this enhanced inflamma-
tory environment. For this, mice were intratracheally inoculated 
with E. coli LPS before infection with B. abortus WT or B. abortus 
btpAbtpB. The pulmonary levels of several proinflammatory 
cytokines were significantly higher in mice of the LPS/btpAbtpB 
group than in those from the LPS/WT group, suggesting that 
Btp proteins modulate the proinflammatory response elicited by 
the LPS pretreatment. Whereas LPS pretreatment did not modify 
the survival of B. abortus WT, it reduced the survival of the 
btpAbtpB mutant. The overall results suggest that the expression 
of Btp proteins does not confer a survival advantage to B. abortus 
in the context of the weak inflammatory environment elicited 
in the lungs by the infection with this pathogen, but may confer 
such advantage within a stronger inflammatory environment. 
Further studies will be required to address this question in differ-
ent models of Brucella infection in vivo. To our best knowledge, 
this is the first study to address the role of Btp proteins in mice 
infected through a natural route for Brucella species, as previous 
studies used intraperitoneal infection (9, 30).
Overall, this study revealed a weak proinflammatory response 
to inhaled B. abortus in murine lungs. In addition, the cytokine 
response started to differentiate from the control group as late 
as 3 days p.i., 2 days after Brucella was first detected in peripheral 
organs. This means that Brucella can disseminate systemically 
before an inflammatory response is achieved in the lungs. 
In the present study, B. abortus was found in spleen and liver as 
early as 1 day after intratracheal infection. These findings are in 
line with those of Archambaud et al., who found the bacterium 
in mediastinal lymph nodes as soon as 1.5 days after intranasal 
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infection (31). According to that report, the bacterium seems to 
be transported out of the lungs by alveolar macrophages and, 
a bit later, by dendritic cells. The present study also suggests that 
the pulmonary inflammatory response mounted at later time 
points has only a limited impact on B. abortus survival in the 
lungs, as CFU counts at 7 days p.i. did not decline as compared 
to the initial inoculum. The limited antimicrobial action of the 
pulmonary innate immunity against Brucella infection may 
also contribute to the efficiency of this pathogen for producing 
systemic disease after inhalation, as the persistent pulmonary 
bacterial pool may constitute a continuous source for dissemina-
tion to peripheral organs.
In summary, this study shows that B. abortus induces only a 
weak inflammatory response in lungs after intratracheal infec-
tion. Whereas the lack of a stronger inflammation is explained in 
part by the modulating effect of Btp proteins on TLR-mediated 
responses, the increased inflammatory response elicited in the 
absence of this modulation is still insufficient for controlling 
B. abortus infection in the lungs. The limited antimicrobial 
action of the pulmonary innate immunity against Brucella infec-
tion may contribute to the efficiency of this pathogen to produce 
systemic disease after inhalation.
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